ArticleFrontiers in immunology2026
Estimating time since influenza virus exposure using single-cell proteomic data.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Determining when the onset of a respiratory infection occurred is important for effective clinical management and can aid in mapping transmission events. However, current diagnostic assays report only pathogen detection status and do not provide any information about the timing of infection, in part because of the lack of biomarkers that inform time since exposure. Methods: To address this gap, we developed immune-based predictive models of infection timing and shedding status using data from a controlled human challenge with influenza A/California/2009 (H1N1), in which major immune cell subsets were longitudinally profiled across multiple time points before and after viral challenge using 42-marker mass cytometry panels. Random forest machine learning models were trained to address two predictive objectives: (1) distinguishing virus shedders from non-shedders and (2) estimating days post-infection challenge (DPC) from immune profiles. Model performance was evaluated within the primary challenge cohort and independently validated using data from a separate controlled human influenza challenge study using the same virus. Results: Our analysis revealed that single-cell immune population dynamics alone encode a robust and reproducible temporal structure following influenza infection, enabling accurate estimation of virus exposure timing. Discussion: These findings provide foundational insight into host immune responses during influenza infection and represent an early step toward a future class of immune-based diagnostics that could extend beyond pathogen detection to inform infection timing and the duration of periods associated with contagiousness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.